Estrogen receptor-β is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast

Anna Sapino, Martino Bosco, Paola Cassoni, Isabella Castellano, Riccardo Arisio, G. Cserni, Angelo P. Dei Tos, Nicoletta Fortunati, Maria G. Catalano, Gianni Bussolati

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

An estrogen dependency has been suggested for the growth of fibroadenomas: however, thus far, none of the steroid hormone receptors acting on breast tissues has been demonstrated in the stroma of breast fibroepithelial lesions. In this study, the expression of estrogen receptor (ER)-α and -β was investigated by immunohistochemistry in 33 fibroadenomas and in 30 benign, three borderline and seven malignant phyllodes tumors, all with spindle cell growth and in one distant metastasis. In addition, the presence of ER-β mRNA and its variants was evaluated by RT-PCR in microdissected stroma. The possible correlation between hormone receptor expression and differentiation processes of stromal cells was investigated by smooth muscle actin and calponin immunostaining. ER-β was the only hormone receptor expressed by stroma of fibroadenomas and phyllodes tumors, both at protein and mRNA level. The highest percentage of ER-β was observed in fibroadenomas with cellular stroma and in phyllodes tumors. In both lesions, ER-β-positive stromal cells showed expression of smooth muscle actin and/or calponin, as demonstrated by double immunostaining. In addition, the mean age at diagnosis was significantly lower in patients with ER-β-positive vs ER-β-negative fibroadenomas. In contrast, in phyllodes tumors, ER-β expression was higher in older patients. In conclusion, (i) only ER-β is detected in the stroma of fibroadenomas and phyllodes tumors; (ii) its expression correlates with the expression of smooth muscle markers and suggests a role of ER-β in myofibroblastic differentiation of stromal cells. These two results, together with the young age of patients carrying fibroadenomas with highly ER-β-positive stroma cells, may further indicate a hormone-receptor mechanism involved in regulating the growth of fibroadenomas. Conversely, the older age of patients with ER-β-rich phyllodes tumors suggests that mechanisms, probably independent from estrogen stimulation, act on the growth of these tumors.

Original languageEnglish
Pages (from-to)599-606
Number of pages8
JournalModern Pathology
Volume19
Issue number4
DOIs
Publication statusPublished - Apr 2006

Fingerprint

Phyllodes Tumor
Fibroadenoma
Stromal Cells
Estrogen Receptors
Breast
Hormones
Smooth Muscle
Growth
Actins
Estrogens
Messenger RNA
Steroid Receptors

Keywords

  • ER-β
  • Fibroadenoma
  • Phyllodes tumor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Estrogen receptor-β is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. / Sapino, Anna; Bosco, Martino; Cassoni, Paola; Castellano, Isabella; Arisio, Riccardo; Cserni, G.; Dei Tos, Angelo P.; Fortunati, Nicoletta; Catalano, Maria G.; Bussolati, Gianni.

In: Modern Pathology, Vol. 19, No. 4, 04.2006, p. 599-606.

Research output: Contribution to journalArticle

Sapino, A, Bosco, M, Cassoni, P, Castellano, I, Arisio, R, Cserni, G, Dei Tos, AP, Fortunati, N, Catalano, MG & Bussolati, G 2006, 'Estrogen receptor-β is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast', Modern Pathology, vol. 19, no. 4, pp. 599-606. https://doi.org/10.1038/modpathol.3800574
Sapino, Anna ; Bosco, Martino ; Cassoni, Paola ; Castellano, Isabella ; Arisio, Riccardo ; Cserni, G. ; Dei Tos, Angelo P. ; Fortunati, Nicoletta ; Catalano, Maria G. ; Bussolati, Gianni. / Estrogen receptor-β is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. In: Modern Pathology. 2006 ; Vol. 19, No. 4. pp. 599-606.
@article{c3f2801077684319ab152ef4b34dd8ed,
title = "Estrogen receptor-β is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast",
abstract = "An estrogen dependency has been suggested for the growth of fibroadenomas: however, thus far, none of the steroid hormone receptors acting on breast tissues has been demonstrated in the stroma of breast fibroepithelial lesions. In this study, the expression of estrogen receptor (ER)-α and -β was investigated by immunohistochemistry in 33 fibroadenomas and in 30 benign, three borderline and seven malignant phyllodes tumors, all with spindle cell growth and in one distant metastasis. In addition, the presence of ER-β mRNA and its variants was evaluated by RT-PCR in microdissected stroma. The possible correlation between hormone receptor expression and differentiation processes of stromal cells was investigated by smooth muscle actin and calponin immunostaining. ER-β was the only hormone receptor expressed by stroma of fibroadenomas and phyllodes tumors, both at protein and mRNA level. The highest percentage of ER-β was observed in fibroadenomas with cellular stroma and in phyllodes tumors. In both lesions, ER-β-positive stromal cells showed expression of smooth muscle actin and/or calponin, as demonstrated by double immunostaining. In addition, the mean age at diagnosis was significantly lower in patients with ER-β-positive vs ER-β-negative fibroadenomas. In contrast, in phyllodes tumors, ER-β expression was higher in older patients. In conclusion, (i) only ER-β is detected in the stroma of fibroadenomas and phyllodes tumors; (ii) its expression correlates with the expression of smooth muscle markers and suggests a role of ER-β in myofibroblastic differentiation of stromal cells. These two results, together with the young age of patients carrying fibroadenomas with highly ER-β-positive stroma cells, may further indicate a hormone-receptor mechanism involved in regulating the growth of fibroadenomas. Conversely, the older age of patients with ER-β-rich phyllodes tumors suggests that mechanisms, probably independent from estrogen stimulation, act on the growth of these tumors.",
keywords = "ER-β, Fibroadenoma, Phyllodes tumor",
author = "Anna Sapino and Martino Bosco and Paola Cassoni and Isabella Castellano and Riccardo Arisio and G. Cserni and {Dei Tos}, {Angelo P.} and Nicoletta Fortunati and Catalano, {Maria G.} and Gianni Bussolati",
year = "2006",
month = "4",
doi = "10.1038/modpathol.3800574",
language = "English",
volume = "19",
pages = "599--606",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Estrogen receptor-β is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast

AU - Sapino, Anna

AU - Bosco, Martino

AU - Cassoni, Paola

AU - Castellano, Isabella

AU - Arisio, Riccardo

AU - Cserni, G.

AU - Dei Tos, Angelo P.

AU - Fortunati, Nicoletta

AU - Catalano, Maria G.

AU - Bussolati, Gianni

PY - 2006/4

Y1 - 2006/4

N2 - An estrogen dependency has been suggested for the growth of fibroadenomas: however, thus far, none of the steroid hormone receptors acting on breast tissues has been demonstrated in the stroma of breast fibroepithelial lesions. In this study, the expression of estrogen receptor (ER)-α and -β was investigated by immunohistochemistry in 33 fibroadenomas and in 30 benign, three borderline and seven malignant phyllodes tumors, all with spindle cell growth and in one distant metastasis. In addition, the presence of ER-β mRNA and its variants was evaluated by RT-PCR in microdissected stroma. The possible correlation between hormone receptor expression and differentiation processes of stromal cells was investigated by smooth muscle actin and calponin immunostaining. ER-β was the only hormone receptor expressed by stroma of fibroadenomas and phyllodes tumors, both at protein and mRNA level. The highest percentage of ER-β was observed in fibroadenomas with cellular stroma and in phyllodes tumors. In both lesions, ER-β-positive stromal cells showed expression of smooth muscle actin and/or calponin, as demonstrated by double immunostaining. In addition, the mean age at diagnosis was significantly lower in patients with ER-β-positive vs ER-β-negative fibroadenomas. In contrast, in phyllodes tumors, ER-β expression was higher in older patients. In conclusion, (i) only ER-β is detected in the stroma of fibroadenomas and phyllodes tumors; (ii) its expression correlates with the expression of smooth muscle markers and suggests a role of ER-β in myofibroblastic differentiation of stromal cells. These two results, together with the young age of patients carrying fibroadenomas with highly ER-β-positive stroma cells, may further indicate a hormone-receptor mechanism involved in regulating the growth of fibroadenomas. Conversely, the older age of patients with ER-β-rich phyllodes tumors suggests that mechanisms, probably independent from estrogen stimulation, act on the growth of these tumors.

AB - An estrogen dependency has been suggested for the growth of fibroadenomas: however, thus far, none of the steroid hormone receptors acting on breast tissues has been demonstrated in the stroma of breast fibroepithelial lesions. In this study, the expression of estrogen receptor (ER)-α and -β was investigated by immunohistochemistry in 33 fibroadenomas and in 30 benign, three borderline and seven malignant phyllodes tumors, all with spindle cell growth and in one distant metastasis. In addition, the presence of ER-β mRNA and its variants was evaluated by RT-PCR in microdissected stroma. The possible correlation between hormone receptor expression and differentiation processes of stromal cells was investigated by smooth muscle actin and calponin immunostaining. ER-β was the only hormone receptor expressed by stroma of fibroadenomas and phyllodes tumors, both at protein and mRNA level. The highest percentage of ER-β was observed in fibroadenomas with cellular stroma and in phyllodes tumors. In both lesions, ER-β-positive stromal cells showed expression of smooth muscle actin and/or calponin, as demonstrated by double immunostaining. In addition, the mean age at diagnosis was significantly lower in patients with ER-β-positive vs ER-β-negative fibroadenomas. In contrast, in phyllodes tumors, ER-β expression was higher in older patients. In conclusion, (i) only ER-β is detected in the stroma of fibroadenomas and phyllodes tumors; (ii) its expression correlates with the expression of smooth muscle markers and suggests a role of ER-β in myofibroblastic differentiation of stromal cells. These two results, together with the young age of patients carrying fibroadenomas with highly ER-β-positive stroma cells, may further indicate a hormone-receptor mechanism involved in regulating the growth of fibroadenomas. Conversely, the older age of patients with ER-β-rich phyllodes tumors suggests that mechanisms, probably independent from estrogen stimulation, act on the growth of these tumors.

KW - ER-β

KW - Fibroadenoma

KW - Phyllodes tumor

UR - http://www.scopus.com/inward/record.url?scp=33645283594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645283594&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800574

DO - 10.1038/modpathol.3800574

M3 - Article

C2 - 16554735

AN - SCOPUS:33645283594

VL - 19

SP - 599

EP - 606

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 4

ER -